| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |